A Novel Vaccine for Cervical Cancer: Quadrivalent Human Papillomavirus (Types 6, 11, 16 and 18) Recombinant Vaccine (Gardasil®)

Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s856
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine

Drugs
Pharmacology
2011English

Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine for the Prevention of Genital Warts in Males

Drugs in R and D
Pharmacology
2012English

Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008–2014

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2019English

Cervical Cancer and the Human Papillomavirus Vaccine

Journal of Family Planning and Reproductive Health Care
2006English

Seroprevalence of Human Papillomavirus Types 6, 11, 16 and 18 in Chinese Women

BMC Infectious Diseases
Infectious Diseases
2012English

PCN89 Public Health Impact of Quadrivalent HPV Types 6, 11, 16, 18 Vaccine in Sao Paulo, Brazil Using a Transmission Dynamic Model

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Calibration of a Cost-Effectiveness Model to Evaluate the Incorporation of a Quadrivalent HPV Types 6, 11, 16, 18 Vaccine in Argentina: Disease Burden Component

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Human Medicines European Public Assessment Report (EPAR): Cervarix, Human Papillomavirus Vaccine [Types 16, 18] (Recombinant, Adjuvanted, Adsorbed), Papillomavirus Infections,Uterine Cervical Dysplasia,Immunization, Date of Authorisation: 20/09/2007, Revision: 32, Status: Authorised

Case Medical Research
2019English

Estimating the Long-Term Impact of a Prophylactic Human Papillomavirus 16/18 Vaccine on the Burden of Cervical Cancer in the UK

British Journal of Cancer
Cancer ResearchOncology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy